Who owns Odyssey Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ODTX from SEC Form 13F filings across 73 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 73 institutions disclosed 37.9M shares of Odyssey Therapeutics, Inc. worth $837.8M — about 78.8% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
73
13F holders
$837.8M
value, 2026 filers
78.8%
of shares outstanding (37.9M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ODTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 6.2M | $135.8M | 0.0% | 13% | +20.5% |
| 2 | SR ONE CAPITAL MANAGEMENT, LP | 3.8M | $84.3M | 7.3% | 7.9% | 0.0% |
| 3 | TPG GP A, LLC | 3.7M | $82.0M | 2.0% | 7.7% | 0.0% |
| 4 | LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 3.6M | $80.2M | 3.9% | 7.5% | 0.0% |
| 5 | ORBIMED ADVISORS LLC | 3.0M | $66.7M | 1.2% | 6.3% | 0.0% |
| 6 | Sanofi | 2.0M | $44.2M | 7.0% | 4.1% | -0.1% |
| 7 | MPM BIOIMPACT LLCNEW | 1.3M | $28.6M | 2.1% | 2.7% | new |
| 8 | Affinity Asset Advisors, LLC | 1.3M | $28.0M | 1.1% | 2.6% | +64.4% |
| 9 | BlackRock, Inc. | 1.1M | $25.4M | 0.0% | 2.4% | +375.4% |
| 10 | DEERFIELD MANAGEMENT COMPANY, L.P. | 1.0M | $23.2M | 0.4% | 2.2% | 0.0% |
| 11 | Woodline Partners LP | 912,340 | $20.3M | 0.1% | 1.9% | +163.9% |
| 12 | Sands Capital Alternatives, LLC | 875,000 | $19.4M | 2.8% | 1.8% | 0.0% |
| 13 | HHLR ADVISORS, LTD. | 831,656 | $18.5M | 1.2% | 1.7% | 0.0% |
| 14 | General Catalyst Group Management, LLC | 810,272 | $18.0M | 3.8% | 1.7% | 0.0% |
| 15 | VANGUARD CAPITAL MANAGEMENT LLC | 734,312 | $16.3M | 0.0% | 1.5% | +1.9% |
| 16 | Foresite Capital Management V, LLC | 729,602 | $16.2M | 5.6% | 1.5% | +2.3% |
| 17 | Vivo Capital, LLC | 575,000 | $12.8M | 1.4% | 1.2% | 0.0% |
| 18 | EcoR1 Capital, LLC | 555,555 | $12.3M | 0.5% | 1.2% | 0.0% |
| 19 | PRICE T ROWE ASSOCIATES INC /MD/ | 491,927 | $10.9M | 0.0% | 1% | +4.2% |
| 20 | Catalio Capital Management, LP | 457,839 | $10.2M | 1.9% | 1% | 0.0% |
| 21 | GEODE CAPITAL MANAGEMENT, LLC | 425,371 | $9.5M | 0.0% | 0.9% | +124.5% |
| 22 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 400,000 | $8.9M | 0.0% | 0.8% | -44.8% |
| 23 | Redmile Group, LLC | 374,510 | $8.3M | 0.6% | 0.8% | -11.9% |
| 24 | STATE STREET CORP | 309,293 | $6.9M | 0.0% | 0.6% | +291.8% |
| 25 | MARSHALL WACE, LLP | 297,041 | $6.6M | 0.0% | 0.6% | -39.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.